SEP-225289

· Sumitomo Pharma America, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SEP-225289, covering 2012-02-23 to 2012-02-23. Get the full timeline:

Most recent: Clinical Trial Update: A Safety, Efficacy and Tolerability Study of SEP-225289 [Phase 2]